10 20 30 40 50 60 70 80 1JZK - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXYGEN STORAGE/TRANSPORT 16-SEP-01 1JZK
TITLE CRYSTAL STRUCTURE OF SCAPHARCA INAEQUIVALVIS HBI, I114F TITLE 2 MUTANT (DEOXY)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLOBIN I - ARK SHELL; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: DIMERIC HEMOGLOBIN, HBI; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCAPHARCA INAEQUIVALVIS; SOURCE 3 ORGANISM_COMMON: ARK CLAM; SOURCE 4 ORGANISM_TAXID: 6561; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: W3110LACIQL8; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCS-26
KEYWDS INVERTEBRATE, HEMOGLOBIN, ALLOSTERY, COOPERATIVITY, OXYGEN- KEYWDS 2 BINDING, OXYGEN-TRANSPORT, HEME PROTEIN, OXYGEN KEYWDS 3 STORAGE/TRANSPORT COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.E.KNAPP,Q.H.GIBSON,L.CUSHING,W.E.ROYER JR.
REVDAT 2 24-FEB-09 1JZK 1 VERSN REVDAT 1 19-DEC-01 1JZK 0
JRNL AUTH J.E.KNAPP,Q.H.GIBSON,L.CUSHING,W.E.ROYER JR. JRNL TITL RESTRICTING THE LIGAND-LINKED HEME MOVEMENT IN JRNL TITL 2 SCAPHARCA DIMERIC HEMOGLOBIN REVEALS TIGHT JRNL TITL 3 COUPLING BETWEEN DISTAL AND PROXIMAL CONTRIBUTIONS JRNL TITL 4 TO COOPERATIVITY. JRNL REF BIOCHEMISTRY V. 40 14795 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11732898 JRNL DOI 10.1021/BI011071T
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.PARDANANI,Q.H.GIBSON,G.COLOTTI,W.E.ROYER JR. REMARK 1 TITL MUTATION OF RESIDUE PHE97 TO LEU DISRUPTS THE REMARK 1 TITL 2 CENTRAL ALLOSTERIC PATHWAY IN SCAPHARCA DIMERIC REMARK 1 TITL 3 HEMOGLOBIN. REMARK 1 REF J.BIOL.CHEM. V. 272 13171 1997 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.272.20.13171 REMARK 1 REFERENCE 2 REMARK 1 AUTH W.E.ROYER JR. REMARK 1 TITL HIGH RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF A REMARK 1 TITL 2 CO-OPERATIVE DIMERIC HEMOGLOBIN. REMARK 1 REF J.MOL.BIOL. V. 235 657 1994 REMARK 1 REFN ISSN 0022-2836
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH&HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1409034.450 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 28818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1410 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2224 REMARK 3 BIN R VALUE (WORKING SET) : 0.1980 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 109 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4476 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.20000 REMARK 3 B22 (A**2) : 3.99000 REMARK 3 B33 (A**2) : -2.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.46000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.07 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.230 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.460 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.160 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 36.79 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PARAM19X.HEME REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : TOPH19X.HEME REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1JZK COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-01. REMARK 100 THE RCSB ID CODE IS RCSB014372.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 296 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28828 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.09300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.17300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 4SDH REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1-2.3M PHOSPHATE BUFFER, PH 7.5, REMARK 280 MICROBATCH, TEMPERATURE 296K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.09000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS EITHER THE AB DIMER OR THE CD REMARK 300 DIMER FOUND IN THE ASSEMETRIC UNIT.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1 REMARK 465 PRO B 1 REMARK 465 PRO C 1 REMARK 465 PRO D 1
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL B 24 -60.73 -94.24 REMARK 500 VAL C 24 -61.06 -91.03 REMARK 500 ASN C 126 30.24 74.89 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 147 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 147 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM C 147 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 147
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JWN RELATED DB: PDB REMARK 900 1JWN IS HBI, I114F MUTANT, CO-LIGATED STRUCTURE REMARK 900 RELATED ID: 3SDH RELATED DB: PDB REMARK 900 3SDH IS WILD TYPE HBI, CO STRUCTURE REMARK 900 RELATED ID: 4SDH RELATED DB: PDB REMARK 900 4SDH IS WILD TYPE HBI, DEOXY STRUCTURE REMARK 900 RELATED ID: 1HBI RELATED DB: PDB REMARK 900 1HBI IS WILD TYPE HBI, OXYGENATED STRUCTURE REMARK 900 RELATED ID: 2HBI RELATED DB: PDB REMARK 900 2HBI IS HBI, F97L MUTANT, DEOXY STRUCTURE REMARK 900 RELATED ID: 3HBI RELATED DB: PDB REMARK 900 3HBI IS HBI, F97L MUTANT, CO-LIGATED STRUCTURE
DBREF 1JZK A 1 146 UNP P02213 GLB1_SCAIN 1 146 DBREF 1JZK B 1 146 UNP P02213 GLB1_SCAIN 1 146 DBREF 1JZK C 1 146 UNP P02213 GLB1_SCAIN 1 146 DBREF 1JZK D 1 146 UNP P02213 GLB1_SCAIN 1 146
SEQADV 1JZK PHE A 114 UNP P02213 ILE 114 ENGINEERED SEQADV 1JZK PHE B 114 UNP P02213 ILE 114 ENGINEERED SEQADV 1JZK PHE C 114 UNP P02213 ILE 114 ENGINEERED SEQADV 1JZK PHE D 114 UNP P02213 ILE 114 ENGINEERED
SEQRES 1 A 146 PRO SER VAL TYR ASP ALA ALA ALA GLN LEU THR ALA ASP SEQRES 2 A 146 VAL LYS LYS ASP LEU ARG ASP SER TRP LYS VAL ILE GLY SEQRES 3 A 146 SER ASP LYS LYS GLY ASN GLY VAL ALA LEU MET THR THR SEQRES 4 A 146 LEU PHE ALA ASP ASN GLN GLU THR ILE GLY TYR PHE LYS SEQRES 5 A 146 ARG LEU GLY ASN VAL SER GLN GLY MET ALA ASN ASP LYS SEQRES 6 A 146 LEU ARG GLY HIS SER ILE THR LEU MET TYR ALA LEU GLN SEQRES 7 A 146 ASN PHE ILE ASP GLN LEU ASP ASN PRO ASP ASP LEU VAL SEQRES 8 A 146 CYS VAL VAL GLU LYS PHE ALA VAL ASN HIS ILE THR ARG SEQRES 9 A 146 LYS ILE SER ALA ALA GLU PHE GLY LYS PHE ASN GLY PRO SEQRES 10 A 146 ILE LYS LYS VAL LEU ALA SER LYS ASN PHE GLY ASP LYS SEQRES 11 A 146 TYR ALA ASN ALA TRP ALA LYS LEU VAL ALA VAL VAL GLN SEQRES 12 A 146 ALA ALA LEU SEQRES 1 B 146 PRO SER VAL TYR ASP ALA ALA ALA GLN LEU THR ALA ASP SEQRES 2 B 146 VAL LYS LYS ASP LEU ARG ASP SER TRP LYS VAL ILE GLY SEQRES 3 B 146 SER ASP LYS LYS GLY ASN GLY VAL ALA LEU MET THR THR SEQRES 4 B 146 LEU PHE ALA ASP ASN GLN GLU THR ILE GLY TYR PHE LYS SEQRES 5 B 146 ARG LEU GLY ASN VAL SER GLN GLY MET ALA ASN ASP LYS SEQRES 6 B 146 LEU ARG GLY HIS SER ILE THR LEU MET TYR ALA LEU GLN SEQRES 7 B 146 ASN PHE ILE ASP GLN LEU ASP ASN PRO ASP ASP LEU VAL SEQRES 8 B 146 CYS VAL VAL GLU LYS PHE ALA VAL ASN HIS ILE THR ARG SEQRES 9 B 146 LYS ILE SER ALA ALA GLU PHE GLY LYS PHE ASN GLY PRO SEQRES 10 B 146 ILE LYS LYS VAL LEU ALA SER LYS ASN PHE GLY ASP LYS SEQRES 11 B 146 TYR ALA ASN ALA TRP ALA LYS LEU VAL ALA VAL VAL GLN SEQRES 12 B 146 ALA ALA LEU SEQRES 1 C 146 PRO SER VAL TYR ASP ALA ALA ALA GLN LEU THR ALA ASP SEQRES 2 C 146 VAL LYS LYS ASP LEU ARG ASP SER TRP LYS VAL ILE GLY SEQRES 3 C 146 SER ASP LYS LYS GLY ASN GLY VAL ALA LEU MET THR THR SEQRES 4 C 146 LEU PHE ALA ASP ASN GLN GLU THR ILE GLY TYR PHE LYS SEQRES 5 C 146 ARG LEU GLY ASN VAL SER GLN GLY MET ALA ASN ASP LYS SEQRES 6 C 146 LEU ARG GLY HIS SER ILE THR LEU MET TYR ALA LEU GLN SEQRES 7 C 146 ASN PHE ILE ASP GLN LEU ASP ASN PRO ASP ASP LEU VAL SEQRES 8 C 146 CYS VAL VAL GLU LYS PHE ALA VAL ASN HIS ILE THR ARG SEQRES 9 C 146 LYS ILE SER ALA ALA GLU PHE GLY LYS PHE ASN GLY PRO SEQRES 10 C 146 ILE LYS LYS VAL LEU ALA SER LYS ASN PHE GLY ASP LYS SEQRES 11 C 146 TYR ALA ASN ALA TRP ALA LYS LEU VAL ALA VAL VAL GLN SEQRES 12 C 146 ALA ALA LEU SEQRES 1 D 146 PRO SER VAL TYR ASP ALA ALA ALA GLN LEU THR ALA ASP SEQRES 2 D 146 VAL LYS LYS ASP LEU ARG ASP SER TRP LYS VAL ILE GLY SEQRES 3 D 146 SER ASP LYS LYS GLY ASN GLY VAL ALA LEU MET THR THR SEQRES 4 D 146 LEU PHE ALA ASP ASN GLN GLU THR ILE GLY TYR PHE LYS SEQRES 5 D 146 ARG LEU GLY ASN VAL SER GLN GLY MET ALA ASN ASP LYS SEQRES 6 D 146 LEU ARG GLY HIS SER ILE THR LEU MET TYR ALA LEU GLN SEQRES 7 D 146 ASN PHE ILE ASP GLN LEU ASP ASN PRO ASP ASP LEU VAL SEQRES 8 D 146 CYS VAL VAL GLU LYS PHE ALA VAL ASN HIS ILE THR ARG SEQRES 9 D 146 LYS ILE SER ALA ALA GLU PHE GLY LYS PHE ASN GLY PRO SEQRES 10 D 146 ILE LYS LYS VAL LEU ALA SER LYS ASN PHE GLY ASP LYS SEQRES 11 D 146 TYR ALA ASN ALA TRP ALA LYS LEU VAL ALA VAL VAL GLN SEQRES 12 D 146 ALA ALA LEU
HET HEM A 147 43 HET HEM B 147 43 HET HEM C 147 43 HET HEM D 147 43
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETSYN HEM HEME
FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 9 HOH *228(H2 O)
HELIX 1 1 SER A 2 ALA A 8 1 7 HELIX 2 2 THR A 11 GLY A 26 1 16 HELIX 3 3 ASP A 28 ASN A 44 1 17 HELIX 4 4 GLN A 45 GLY A 55 5 11 HELIX 5 5 ASN A 56 ALA A 62 5 7 HELIX 6 6 ASN A 63 GLN A 83 1 21 HELIX 7 7 ASN A 86 ARG A 104 1 19 HELIX 8 8 SER A 107 GLY A 112 1 6 HELIX 9 9 PHE A 114 LYS A 125 1 12 HELIX 10 10 GLY A 128 ALA A 144 1 17 HELIX 11 11 SER B 2 ALA B 8 1 7 HELIX 12 12 THR B 11 GLY B 26 1 16 HELIX 13 13 ASP B 28 ASN B 44 1 17 HELIX 14 14 GLN B 45 GLY B 55 5 11 HELIX 15 15 ASN B 56 ALA B 62 5 7 HELIX 16 16 ASN B 63 GLN B 83 1 21 HELIX 17 17 ASN B 86 ARG B 104 1 19 HELIX 18 18 SER B 107 GLY B 112 1 6 HELIX 19 19 PHE B 114 LYS B 125 1 12 HELIX 20 20 GLY B 128 ALA B 144 1 17 HELIX 21 21 SER C 2 ALA C 8 1 7 HELIX 22 22 THR C 11 GLY C 26 1 16 HELIX 23 23 ASP C 28 ASN C 44 1 17 HELIX 24 24 GLN C 45 GLY C 55 5 11 HELIX 25 25 ASN C 56 ALA C 62 5 7 HELIX 26 26 ASN C 63 GLN C 83 1 21 HELIX 27 27 ASN C 86 ARG C 104 1 19 HELIX 28 28 SER C 107 GLY C 112 1 6 HELIX 29 29 PHE C 114 SER C 124 1 11 HELIX 30 30 GLY C 128 ALA C 144 1 17 HELIX 31 31 SER D 2 ALA D 8 1 7 HELIX 32 32 THR D 11 GLY D 26 1 16 HELIX 33 33 ASP D 28 ASN D 44 1 17 HELIX 34 34 GLN D 45 GLY D 55 5 11 HELIX 35 35 ASN D 56 ALA D 62 5 7 HELIX 36 36 ASN D 63 GLN D 83 1 21 HELIX 37 37 ASN D 86 ARG D 104 1 19 HELIX 38 38 SER D 107 GLY D 112 1 6 HELIX 39 39 PHE D 114 LYS D 125 1 12 HELIX 40 40 GLY D 128 ALA D 144 1 17
LINK NE2 HIS A 101 FE HEM A 147 1555 1555 2.05 LINK NE2 HIS B 101 FE HEM B 147 1555 1555 2.07 LINK NE2 HIS C 101 FE HEM C 147 1555 1555 2.07 LINK NE2 HIS D 101 FE HEM D 147 1555 1555 2.06
SITE 1 AC1 14 TYR A 50 PHE A 51 ARG A 53 PHE A 97 SITE 2 AC1 14 ASN A 100 HIS A 101 ARG A 104 ILE A 106 SITE 3 AC1 14 PHE A 111 PHE A 114 HOH A 158 HOH A 164 SITE 4 AC1 14 LYS B 96 ASN B 100 SITE 1 AC2 16 LYS A 96 ASN A 100 TYR B 50 PHE B 51 SITE 2 AC2 16 ARG B 53 HIS B 69 PHE B 97 ASN B 100 SITE 3 AC2 16 HIS B 101 ARG B 104 ILE B 106 PHE B 111 SITE 4 AC2 16 PHE B 114 HOH B 154 HOH B 160 HOH B 169 SITE 1 AC3 15 TYR C 50 PHE C 51 ARG C 53 HIS C 69 SITE 2 AC3 15 PHE C 97 ASN C 100 HIS C 101 ARG C 104 SITE 3 AC3 15 ILE C 106 PHE C 111 PHE C 114 HOH C 162 SITE 4 AC3 15 HOH C 201 LYS D 96 ASN D 100 SITE 1 AC4 15 LYS C 96 ASN C 100 TYR D 50 PHE D 51 SITE 2 AC4 15 ARG D 53 HIS D 69 PHE D 97 ASN D 100 SITE 3 AC4 15 HIS D 101 ARG D 104 ILE D 106 PHE D 111 SITE 4 AC4 15 PHE D 114 HOH D 167 HOH D 193
CRYST1 83.720 44.180 87.230 90.00 115.49 90.00 P 1 21 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011945 0.000000 0.005695 0.00000
SCALE2 0.000000 0.022635 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012700 0.00000